European Archives - Page 94 of 1168 - European Medical Journal

EMJ Oncology 13 [Supplement 1] 2025

Endometrial cancer is one of the most common gynaecological cancers in high-income countries and, for many years, has been associated…

Illuminating Tumour Biology: MammaPrint® and BluePrint® Genomic Insights from SABCS 2024 to Optimise Breast Cancer Care

During this webinar, William Audeh, Joyce O’Shaughnessy, and Adam Brufsky present the latest MammaPrint and BluePrint data that was…

Advancements in Endometrial Cancer Research in 2024

Join Dr. Brigitte Scott and Professor Ketta Lorusso, a leading expert in gynecological malignancies, for an in-depth video interview…

Anxiety Trends in People with HCV Who Inject Drugs

This study aimed to explore anxiety trends among HCV-infected people who inject drugs.

FAB Score: A New Tool for Predicting Mortality in Adult Fontan

New research shows how the FAB Score predicts mortality risk in adult Fontan patients with 92% accuracy.

Prednisolone Initiation Before Specialist Visit Complicates Polymyalgia Rheumatica Diagnosis

Initiating steroid treatment before specialist evaluation may obscure the clinical signs of polymyalgia rheumatica, reducing diagnostic accuracy.

Pregnancy Blood Pressure Trajectories May Predict Long-Term Hypertension Risk

Gestational blood pressure trajectories are linked to long-term hypertension risk, highlighting the need for better postpartum monitoring.

Aspirin and COX-1 Inhibitors Show Promise in Preventing Cancer Metastasis

Aspirin and COX-1 inhibitors may reduce cancer metastasis by enhancing T cell immunity, offering a new treatment approach.

Annual Lenacapavir Injection Could Revolutionise HIV PrEP

New findings highlight the potential of once-yearly intramuscular lenacapavir for PrEP, offering a long-acting alternative that could reduce barriers to HIV prevention.

Intestinal Ultrasound Detects Hidden IBD Risks During Pregnancy

A large international study shows that intestinal ultrasound during pregnancy can reveal hidden inflammatory bowel disease activity, significantly improving prediction of complications like preterm birth and preeclampsia, beyond what clinical symptoms and lab tests can detect.